Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNET HR Protocol for High-Risk Brain Tumors
NCT00180791Phase 2Unknown
- Sponsor
- Gustave Roussy
- Start
- Jul 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, carboplatin, melphalan, cisplatin, thiotepa in medulloblastoma, primitive neuroectodermal tumor (PNET), sponsored by Gustave Roussy. Status: unknown.
02
Drugs
etoposidecarboplatinmelphalancisplatinthiotepa
03
Conditions
medulloblastomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00180791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180791.